A new study has discovered the reason why men tend to sustain more heart muscle damage following a heart attack than women: ...

Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.

It can thus be argued that, 'spiritually' at least, the interleukin-6 (IL-6) inhibitor Actemra (tocilizumab) belongs to the class of 2009. The drug, developed by Genentech, of S. San Francisco ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Sound evidence for fetal/child safety is still lacking for certolizumab, golimumab, abatacept, tocilizumab ... and cytotoxic drugs are used defined pregnancy outcomes cannot be assigned to each of ...

Other outcomes were adverse drug reactions ... ranging from 23.5% for tocilizumab to 72.7% for etanercept), loss of efficacy (18.1%) and ADRs (20.9%; mostly for anakinra: 46.7%). Persistence was ...

The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

Conclusion: Tocilizumab, a novel IL-6R inhibitor, may be beneficial for the treatment of RA in patients who do not respond to methotrexate or disease-modifying antirheumatic drugs. A large ...

seizing drugs and offensive weapons. Officers were called to Hancock Street and seized a quantity of class A drugs, along with zombie knives and other offensive weapons. Police want to remind the ...